Selective Histone Deacetylase Isoforms as Potential Therapeutic Targets
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 247
Special Issue Editor
Interests: drug design; molecular modeling; molecular dynamics; virtual screening; pharmacophore modeling; drug repurposing; natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Due to the crucial role of histone deacetylases (HDACs) in regulating fundamental cellular processes, this thematic issue aims to highlight important advances in the field of HDACs, including their inhibitors and activators and their pharmacological applications in cancer, neurodegenerative and inflammatory diseases.
The sub-topics to be covered within the issue will be:
- HDAC inhibitors as anti-inflammatory agents with a novel mechanism of action;
- HDAC inhibitors targeting the tumor microenvironment: new perspectives;
- HDAC inhibitor applications in neurodegenerative and psychiatric disorders;
- HDAC inhibitors as novel antidiabetic agents;
- HDAC activators and inflammation.
Prof. Dr. Anna Artese
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
